Developer docs
API playgroundTry for free, no card

Search company profiles

ALS United

Full company profile

uuid0069ia4

Namestring
ALS United
Legal namestring
ALS United®
Websiteurl
alsunited.org
Company typeenum
Private
Founded yearint
2023
Descriptiontext

ALS United is a U.S. nonprofit federation formed in 2023 that unites 15 independent member organizations to deliver care, services, advocacy, and research funding for people living with amyotrophic lateral sclerosis (ALS) and their families. Headquartered in Beaverton, Oregon, and led by CEO Jerry Dawson and Board Chair Jim Mortensen, the federation channels more than $40 million in combined annual member-organization revenue toward ALS programs and supports a national network of 90+ multidisciplinary ALS clinics, support groups, and community fundraising chapters. Its federal advocacy work has been a primary driver behind the ACT for ALS Act (2021), the ALS Disability Insurance Access Act (2020), the Senator Elizabeth Dole Act (2025), and the 2022 FDA approval pathway for Tofersen.

Its core products and technology platforms include the ALS United mobile app (which integrates with Apple Health and fitness activity tracking for symptom and progression monitoring) and the ALS Knowledge Portal (a researcher-facing data infrastructure asset consolidating the ALL ALS Consortium, with 1,200+ enrolled participants and tens of thousands of contributed biosamples). The federation has committed nearly $3 million to research for FY 2024-2025, including a $500,000 commitment to the Accelerating Medicines Partnership for ALS (AMP ALS), and partners with NIH, FDA, the Foundation for the National Institutes of Health (FNIH), NEALS, AMP ALS, the American Brain Foundation, the Critical Path Institute, and the Congressional ALS Caucus.

Its business model is federated nonprofit funding. Member organizations operate locally on diversified revenue streams including individual donations, legacy gifts, corporate sponsorships, and grassroots events such as Walks, rides, and galas, while the national federation coordinates advocacy, shared digital infrastructure, and pooled research grant-making. Through the ACT for ALS Expanded Access Programs, more than 700 patients have received investigational therapies, and the broader federation model is designed to consolidate administrative scale, expand policy influence, and centralize research investment across the previously independent chapters.

Short descriptiontext

ALS United is a nonprofit federation of 15 member organizations delivering ALS care services, clinical network support, research funding, and federal advocacy across the United States from its Beaverton, Oregon headquarters.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersBeaverton, United States
HQ citystring
Beaverton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ALS patient support, ALS care services, ALS research funding, Disease advocacy services, Caregiver support programs
Industry1 code
1Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryYes
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Services for the Elderly and Persons with Disabilities62412
SIC code1 code
  • Services-Social Services8300
Product category
Nonprofit ALS Patient Support Services
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Donations and Fundraising
TypeOthers
Description

Individual and corporate donations are the primary revenue source. The majority of donations to ALS United are directed to member organizations for local ALS care and research. The organization processes donations through its website and app.

alsunited.org
2Member Dues
TypeSubscription Recurring
Description

Member organizations pay dues that fund core operations of ALS United national organization. Each of the 15 independent member organizations contributes dues based on their revenue and capacity.

alsunited.org
3Federal Research Grants
TypeGrants Donations
Description

ALS United and its members receive federal funding through NIH and Congressionally Directed Medical Research Program (CDMRP) for ALS research initiatives. For fiscal year 2024-2025, members committed nearly $3 million to research including AMP ALS, ALS Research Network, fellowships, and clinical trials.

alsunited.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

ALS United is a national nonprofit federation of 15 independent member organizations that deliver local ALS care, support, and community resources to people living with Amyotrophic Lateral Sclerosis (ALS) and their families. The organization coordinates multidisciplinary clinic access, respite care grants, equipment loans, transportation assistance, support groups, and direct financial aid, while funding approximately $3 million annually in ALS research and advocating for federal policy changes including ACT for ALS legislation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 700+ people living with ALS received access to investigational therapies through 5 NIH Expanded Access Programs
+4 more records
Product overview1 text field

ALS United operates as a nonprofit federation providing a suite of services for the ALS community rather than a single unified product. The core offerings include the ALS United mobile app for activity tracking and fundraising, the ALS Knowledge Portal for research data sharing, and the ALS Clinic Finder for locating specialized care. The organization coordinates 15 independent member organizations through a network model, each providing localized support services such as respite care, equipment loans, and support groups. Research initiatives are advanced through partnerships with prestigious institutions including AMP ALS, NEALS, and the American Brain Foundation. Advocacy services include a digital platform for Congressional outreach. The product architecture combines direct-to-patient tools (mobile app, clinic finder) with researcher-facing platforms (knowledge portal, clinical trial finder) and community coordination infrastructure.

Product and service7 records
1ALS United Mobile App
CategoryMobile Application
2ALS Knowledge Portal
CategoryResearch Data Platform
3ALS Clinic Finder
CategoryDirectory Service
4Clinical Trials Finder
CategoryDirectory Service
5Member Organization Network (Local ALS Support Services)
CategoryLocal Care Support Services
6Advocacy Action Alerts Platform
CategoryAdvocacy Platform
7ALS Research Funding Programs
CategoryResearch Grants
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
1Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

ALS United supports AMP ALS with a $500,000 commitment from members. This public-private partnership includes NIH, FNIH, FDA, pharmaceutical and biotechnology companies, and nonprofit organizations. The initiative addresses disease heterogeneity, fragmented research efforts, and lack of standardized clinical tools through a central ALS Knowledge Platform for data sharing and biomarker validation.

alsunited.org
2Northeast ALS Consortium (NEALS)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ALS United and its members partner with NEALS, the largest clinical research organization dedicated to ALS. NEALS conducts clinical trials and provides a trial finder tool to help patients find appropriate research studies.

alsunited.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership to advance neurological research, including ALS research initiatives supported by ALS United members through funding and collaborative research programs.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Initiative supporting innovative research approaches to ALS treatment and cure. Members pool resources to fund cutting-edge research projects and emerging therapeutic strategies.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Network of researchers and institutions collaborating on ALS clinical trials and research studies, funded through member commitments for the current fiscal year.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NIH administers the ACT for ALS Expanded Access Programs, ALL ALS Consortium natural history study (1,200+ participants), Rare Disease Grant Program, and shared data infrastructure. NIH has launched five EAPs providing access to investigational therapies for 700+ people with ALS.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

FDA partners through AMP ALS and CP-RND (Critical Path for Rare Neurodegenerative Diseases) initiative to develop common data standards and fit-for-purpose tools to evaluate ALS treatments more efficiently, including biomarkers and clinical outcome assessments.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

FNIH manages the AMP-ALS public-private partnership and ALS Knowledge Portal, aligning federal agencies, academic scientists, companies, and nonprofits around shared data and shared priorities for ALS research.

990+ Multidisciplinary ALS Clinics
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ALS United partners with 90+ multidisciplinary ALS clinics nationwide to ensure access to specialized coordinated care. These clinics feature teams including neurologists, respiratory therapists, physical therapists, occupational therapists, speech pathologists, dietitians, social workers, and mental health professionals.

alsunited.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

C-Path participates in AMP ALS as part of the public-private partnership, contributing to the development of biomarkers, modeling platforms, and clinical outcome assessments for ALS treatment evaluation.

11Congressional ALS Caucus
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Bipartisan Congressional caucus focused on practical policy solutions and sustained research investment for people living with ALS. ALS United advocates for Representatives to join and support the caucus.

alsunited.org
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries15 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ALS United

Nonprofit ALS Patient Support Servicesalsunited.org

ALS United is a nonprofit federation of 15 member organizations delivering ALS care services, clinical network support, research funding, and federal advocacy across the United States from its Beaverton, Oregon headquarters.

What ALS United does

ALS United is a U.S. nonprofit federation formed in 2023 that unites 15 independent member organizations to deliver care, services, advocacy, and research funding for people living with amyotrophic lateral sclerosis (ALS) and their families. Headquartered in Beaverton, Oregon, and led by CEO Jerry Dawson and Board Chair Jim Mortensen, the federation channels more than $40 million in combined annual member-organization revenue toward ALS programs and supports a national network of 90+ multidisciplinary ALS clinics, support groups, and community fundraising chapters. Its federal advocacy work has been a primary driver behind the ACT for ALS Act (2021), the ALS Disability Insurance Access Act (2020), the Senator Elizabeth Dole Act (2025), and the 2022 FDA approval pathway for Tofersen.

Its core products and technology platforms include the ALS United mobile app (which integrates with Apple Health and fitness activity tracking for symptom and progression monitoring) and the ALS Knowledge Portal (a researcher-facing data infrastructure asset consolidating the ALL ALS Consortium, with 1,200+ enrolled participants and tens of thousands of contributed biosamples). The federation has committed nearly $3 million to research for FY 2024-2025, including a $500,000 commitment to the Accelerating Medicines Partnership for ALS (AMP ALS), and partners with NIH, FDA, the Foundation for the National Institutes of Health (FNIH), NEALS, AMP ALS, the American Brain Foundation, the Critical Path Institute, and the Congressional ALS Caucus.

Its business model is federated nonprofit funding. Member organizations operate locally on diversified revenue streams including individual donations, legacy gifts, corporate sponsorships, and grassroots events such as Walks, rides, and galas, while the national federation coordinates advocacy, shared digital infrastructure, and pooled research grant-making. Through the ACT for ALS Expanded Access Programs, more than 700 patients have received investigational therapies, and the broader federation model is designed to consolidate administrative scale, expand policy influence, and centralize research investment across the previously independent chapters.

ALS United firmographics

Firmographics
Name
ALS United
Legal name
ALS United®
Website
https://alsunited.org
Company type
Private
Founded year
2023
Operating status
Operating
Short description
ALS United is a nonprofit federation of 15 member organizations delivering ALS care services, clinical network support, research funding, and federal advocacy across the United States from its Beaverton, Oregon headquarters.
Ownership category
akta.pro rank

ALS United industry classification

Industry
Product category
Nonprofit ALS Patient Support Services
NAICS
Voluntary Health Organizations (813212), Services for the Elderly and Persons with Disabilities (62412)
SIC
Services-Social Services (8300)
akta.pro primary industry
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

  • ALS patient support
  • ALS care services
  • ALS research funding
  • Disease advocacy services
  • Caregiver support programs

Where ALS United is headquartered

Location

Headquarters

HQ city
Beaverton
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ALS United business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Donations and Fundraising: Individual and corporate donations are the primary revenue source. The majority of donations to ALS United are directed to member organizations for local ALS care and research. The organization processes donations through its website and app.
  2. Member Dues: Member organizations pay dues that fund core operations of ALS United national organization. Each of the 15 independent member organizations contributes dues based on their revenue and capacity.
  3. Federal Research Grants: ALS United and its members receive federal funding through NIH and Congressionally Directed Medical Research Program (CDMRP) for ALS research initiatives. For fiscal year 2024-2025, members committed nearly $3 million to research including AMP ALS, ALS Research Network, fellowships, and clinical trials.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

ALS United product offering

Product offering

Core offering

ALS United is a national nonprofit federation of 15 independent member organizations that deliver local ALS care, support, and community resources to people living with Amyotrophic Lateral Sclerosis (ALS) and their families. The organization coordinates multidisciplinary clinic access, respite care grants, equipment loans, transportation assistance, support groups, and direct financial aid, while funding approximately $3 million annually in ALS research and advocating for federal policy changes including ACT for ALS legislation.

Product overview

ALS United operates as a nonprofit federation providing a suite of services for the ALS community rather than a single unified product. The core offerings include the ALS United mobile app for activity tracking and fundraising, the ALS Knowledge Portal for research data sharing, and the ALS Clinic Finder for locating specialized care. The organization coordinates 15 independent member organizations through a network model, each providing localized support services such as respite care, equipment loans, and support groups. Research initiatives are advanced through partnerships with prestigious institutions including AMP ALS, NEALS, and the American Brain Foundation. Advocacy services include a digital platform for Congressional outreach. The product architecture combines direct-to-patient tools (mobile app, clinic finder) with researcher-facing platforms (knowledge portal, clinical trial finder) and community coordination infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

  • ALS United Mobile App
  • ALS Knowledge Portal
  • ALS Clinic Finder
  • Clinical Trials Finder
  • Member Organization Network (Local ALS Support Services)
  • Advocacy Action Alerts Platform
  • ALS Research Funding Programs

Quantifiable outcome

  • 700+ people living with ALS received access to investigational therapies through 5 NIH Expanded Access Programs
  • +4 more outcomes

Companies that use ALS United

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles5 records

ALS United technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

Feature2 records

ALS United partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and major.

  • Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS)coreStrategic or Co-development Partner · 1 February 2024ALS United supports AMP ALS with a $500,000 commitment from members. This public-private partnership includes NIH, FNIH, FDA, pharmaceutical and biotechnology companies, and nonprofit organizations. The initiative addresses disease heterogeneity, fragmented research efforts, and lack of standardized clinical tools through a central ALS Knowledge Platform for data sharing and biomarker validation.
  • Northeast ALS Consortium (NEALS)coreStrategic or Co-development PartnerALS United and its members partner with NEALS, the largest clinical research organization dedicated to ALS. NEALS conducts clinical trials and provides a trial finder tool to help patients find appropriate research studies.
  • American Brain FoundationmajorStrategic or Co-development PartnerPartnership to advance neurological research, including ALS research initiatives supported by ALS United members through funding and collaborative research programs.
  • ALS Research Innovation InitiativemajorStrategic or Co-development PartnerInitiative supporting innovative research approaches to ALS treatment and cure. Members pool resources to fund cutting-edge research projects and emerging therapeutic strategies.
  • ALS Research NetworkmajorStrategic or Co-development PartnerNetwork of researchers and institutions collaborating on ALS clinical trials and research studies, funded through member commitments for the current fiscal year.
  • NIH (National Institutes of Health)coreStrategic or Co-development PartnerNIH administers the ACT for ALS Expanded Access Programs, ALL ALS Consortium natural history study (1,200+ participants), Rare Disease Grant Program, and shared data infrastructure. NIH has launched five EAPs providing access to investigational therapies for 700+ people with ALS.
  • FDA (Food and Drug Administration)coreStrategic or Co-development PartnerFDA partners through AMP ALS and CP-RND (Critical Path for Rare Neurodegenerative Diseases) initiative to develop common data standards and fit-for-purpose tools to evaluate ALS treatments more efficiently, including biomarkers and clinical outcome assessments.
  • Foundation for the National Institutes of Health (FNIH)coreStrategic or Co-development PartnerFNIH manages the AMP-ALS public-private partnership and ALS Knowledge Portal, aligning federal agencies, academic scientists, companies, and nonprofits around shared data and shared priorities for ALS research.
  • 90+ Multidisciplinary ALS ClinicscoreStrategic or Co-development PartnerALS United partners with 90+ multidisciplinary ALS clinics nationwide to ensure access to specialized coordinated care. These clinics feature teams including neurologists, respiratory therapists, physical therapists, occupational therapists, speech pathologists, dietitians, social workers, and mental health professionals.
  • Critical Path Institute (C-Path)majorStrategic or Co-development PartnerC-Path participates in AMP ALS as part of the public-private partnership, contributing to the development of biomarkers, modeling platforms, and clinical outcome assessments for ALS treatment evaluation.
  • Congressional ALS CaucuscoreStrategic or Co-development PartnerBipartisan Congressional caucus focused on practical policy solutions and sustained research investment for people living with ALS. ALS United advocates for Representatives to join and support the caucus.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

ALS United competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key highlights6 records

Customer concentration

ALS United financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ALS United leadership team

Management profile

Number of profiles

Profiles17 records

ALS United subsidiaries and ownership

Company hierarchy

Subsidiaries15 records

ALS United funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ALS United M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ALS United

What does ALS United do?

ALS United is a national nonprofit federation of 15 independent member organizations that deliver local ALS care, support, and community resources to people living with Amyotrophic Lateral Sclerosis (ALS) and their families. The organization coordinates multidisciplinary clinic access, respite care grants, equipment loans, transportation assistance, support groups, and direct financial aid, while funding approximately $3 million annually in ALS research and advocating for federal policy changes including ACT for ALS legislation.

Is ALS United a public or private company?

ALS United is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was ALS United founded?

ALS United was founded in 2023.

Where is ALS United based?

ALS United is headquartered in Beaverton, United States, in the North America region.

How does ALS United make money?

Three revenue lines are on record. Donations and Fundraising is the primary driver. The others are member Dues and federal Research Grants.

Does ALS United have an API?

No public API is recorded for ALS United.

What industry is ALS United in?

ALS United's product category is Nonprofit ALS Patient Support Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireCongress Must Finish the Job on ACT for ALS Reauthorization Before Recess, Says ALS UnitedALS United urged Congress to reconcile House and Senate versions of the ACT for ALS reauthorization before the fall recess. The House passed H.R. 8205 and the Senate passed S. 4472, with Dawson saying each week of delay costs patients time. The law's expanded access programs and research infrastructure face expiration without reauthorization.PR NewswireALS Network and ALS United Announce Call for Letters of Intent for New ALS Research FundingThe ALS Network and ALS United announced that Letters of Intent for ALS research funding will be accepted from March 16 through April 20, 2026, as part of their expanding ALS Research Innovation Initiative. The joint funding opportunity aims to support innovative research proposals designed to accelerate discoveries and improve outcomes for people living with amyotrophic lateral sclerosis. Researchers and institutions interested in applying are encouraged to review guidelines and submit proposals during the specified application window.PR NewswireALS Northwest ends 2025 with Significant Research InvestmentALS Northwest increased its financial investment in ALS research throughout 2025, participating in an initiative to pool funding with 11 other ALS United member organizations to support a portfolio of research innovation grants. The organization expanded its research funding amid federal cuts threatening momentum in the field, partnering with the ALS Network to reduce infrastructure costs and maximize direct funding to science. This investment reflects ALS Northwest's commitment to accelerating breakthroughs in ALS treatment and care through collaborative funding efforts.PR NewswireALS United Greater Chicago Ends 2025 with Significant Research InvestmentALS United Greater Chicago increased its financial investment in ALS research throughout 2025, expanding collaboration with 11 other ALS United member organizations to fund a portfolio of research innovation grants through the ALS Network's centralized research program. The initiative aims to counteract momentum loss caused by federal funding cuts threatening the field. The partnership reduces infrastructure costs and eliminates duplication while increasing direct funding for promising scientific projects.PR NewswireALS United Connecticut Ends 2025 with Significant Research InvestmentALS United Connecticut increased its financial investment in ALS research during 2025, joining an initiative with 11 other member organizations to fund a portfolio of research innovation grants. This collaborative effort aims to accelerate treatment and prevention while reducing infrastructure costs through the ALS Network. The funding expansion occurs amidst concerns that federal cuts may threaten momentum in the field.PR NewswireALS United Greater New York ends 2025 with Significant Research InvestmentALS United Greater New York increased its financial investment in ALS research throughout 2025, partnering with 11 other ALS United member organizations to fund a portfolio of research innovation grants through the ALS Network. The organization expanded its research funding amid concerns that federal cuts threaten momentum in the ALS field. The collaboration aims to reduce infrastructure costs, eliminate duplication, and increase direct funding for scientific discovery.PR NewswireALS Network and ALS United Announce New Research GranteesThe ALS Network, in partnership with 12 ALS United member organizations, announced its 2025 Research Innovation Grantees—a group of scientists and clinicians receiving funding for ALS treatment, prevention, and discovery research at institutions including Washington University, UCSF, UC San Diego, and Harvard. The grants, awarded through a competitive process reviewed by the ALS Network's Scientific Advisory Committee and Community Research Committee, support work across genetics, environmental studies, regenerative medicine, biomarker discovery, and clinical interventions. The article notes that federal funding cuts threaten momentum in the field, and the partnership is structured to reduce infrastructure costs and eliminate duplication while increasing direct funding to researchers.PR NewswireRobert Packard Center for ALS Research and ALS United Announce Joint Research Funding PartnershipThe Robert Packard Center for ALS Research at Johns Hopkins and ALS United announced a joint research funding partnership to co-fund preclinical basic science research into amyotrophic lateral sclerosis. The co-funded grant will support research led by Albert La Spada (University of California, Irvine) and Sandrine Da Cruz (VIB – KU Leuven) investigating Alternative Polyadenylation-Driven Subcellular RNA Mislocalization in TDP-43 Proteinopathies, aiming to identify novel pathways and therapeutic targets for ALS.